logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q4 Earnings Report

Below are the earnings highlights for CTI BioPharma Corp. (CTIC):

-Earnings: -$8.19 million in Q4 vs. $0.85 million in the same period last year.
-EPS: -$0.14 in Q4 vs. $0.01 in the same period last year.
-Analysts projected -$0.22 per share

For comments and feedback contact: editorial@rttnews.com

Follow RTT